Phase II trial of dose-dense chemotherapy followed by dose-intense erlotinib for patients with newly diagnosed metastatic non-small cell lung cancer

por PETTY, W. JEFFREY, LAUDADIO, JENNIFER, BRAUTNICK, LYNSAY, LOVATO, JAMES, DOTSON, TRAVIS, STREER, NATHAN P., WEAVER, KATHRYN E., MILLER, ANTONIUS A.
Publicado 2013

Dysregulated Pyrimidine Biosynthesis Contributes to 5-FU Resistance in SCLC Patient-Derived Organoids but Response to a Novel Polymeric Fluoropyrimidine, CF10

por Gmeiner, William H., Miller, Lance D., Chou, Jeff W., Dominijanni, Anthony, Mutkus, Lysette, Marini, Frank, Ruiz, Jimmy, Dotson, Travis, Thomas, Karl W., Parks, Graham, Bellinger, Christina R.
Publicado 2020

Comprehensive and Computable Molecular Diagnostic Panel (C2Dx) From Small Volume Specimens for Precision Oncology: Molecular Subtyping of Non-Small Cell Lung Cancer From Fine Needl...

por Su, Jing, Huang, Lynn S., Barnard, Ryan, Parks, Graham, Cappellari, James, Bellinger, Christina, Dotson, Travis, Craddock, Lou, Prakash, Bharat, Hovda, Jonathan, Clark, Hollins, Petty, William Jeffrey, Pasche, Boris, Chan, Michael D., Miller, Lance D., Ruiz, Jimmy
Publicado 2021

Identification of CD37, cystatin A, and IL-23A gene expression in association with brain metastasis: analysis of a prospective trial

por Dohm, Ammoren, Su, Jing, McTyre, Emory R., Taylor, James M., Miller, Lance D., Petty, W. Jeffrey, Xing, Fei, Lo, Hui-Wen, Metheny-Barlow, Linda J., O’Neill, Stacey, Bellinger, Christina, Dotson, Travis, Pasche, Boris, Watabe, Kounosuke, Chan, Michael D., Ruiz, Jimmy
Publicado 2019

Clinical validation and utility of Percepta GSC for the evaluation of lung cancer

por Mazzone, Peter, Dotson, Travis, Wahidi, Momen M., Bernstein, Michael, Lee, Hans J., Feller Kopman, David, Yarmus, Lonny, Whitney, Duncan, Stevenson, Christopher, Qu, Jianghan, Johnson, Marla, Walsh, P. Sean, Huang, Jing, Lofaro, Lori R., Bhorade, Sangeeta M., Kennedy, Giulia C., Spira, Avrum, Rivera, M. Patricia
Publicado 2022